2021 Virtual Workshop – Innovative Approaches to Drug Safety
Register Workshop information flyer
December 8, 2020
Share on facebook
Share on twitter
Share on linkedin
Menu
A revolution in Pharmacovigilance
Our Services
ADE Capture
Case Processing
Research & Analytics
Workshop
eVERA is cloud based pharmacovigilance platform that captures, processes, and analyzes adverse events, with the ultimate goal of providing our primary business customer, the manufacturers, with abundant real-world evidence, enabling a better understanding of the benefits and risks of their products.
Simplification reduces administrative burden and reduces costs of collection and processing of adverse drug effects.
Solicitation of adverse drug effects directly from the public is a unique approach to fulfilling industry reporting obligations and improving epidemiological parameters.
Automation of data capture minimizes human input and reduce time and cost required to process adverse drug events.
Reuse of collected and processed data enables users to satisfy obligations to all interested stakeholders and ADE collecting systems investing very little effort.
Improved system transparency. High quality reports produce more accurate estimate of epidemiological indicators and patterns of use.
Linking patient with the pharmacist and physician enables reconciliation of prescribed vs. dispensed vs. used medication and facilitates follow-up.
Virtual label flags issues such as drug interactions, overdose, off-label use and contraindications, highlights pharmacogenomic considerations and suggests therapeutic alternatives.
Analytical dashboard responsive to stakeholders’ needs enables insight into own performance and quality of care indicators through customized enriched datasets.
Our Latest posts
How credible are the adverse drug events manufacturers receive?
Collecting adverse drug events from healthcare professionals and the public is mandatory for manufacturers. Minimum criteria apply to make such a case report valid. A valid
October 22, 2020
Will pharmacogenomic testing become a routine part of clinical care?
Some adverse drug events are a predictable consequence of therapeutic, especially dosing failures. Idiosyncratic toxicities, on the other hand, are much less predictable and much more
September 28, 2020
Utilizing pharmacogenomic testing to ensure effective therapy
Some medications are administered as prodrugs that need to be metabolized in the active form by the body. An example of such a drug is codeine.
September 17, 2020
Adverse incidents of medical devices
Medical Devices Regulation 2017/745 and In Vitro Diagnostic Medical Devices Regulation 2017/746 The new European legislation places numerous new obligations on manufacturers of medical devices marketed
August 17, 2020
Subscribe to our newsletter
Head Office
- Gladwyne, PA 19072
- 610-745-5995
- mail@veracuity.com
Company
Menu
Services
Menu
Support
Menu